Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation.
Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation. Eur J Pharmacol. 2019 Nov 05; 862:172627.
View in:
PubMed
subject areas
Adenosine Diphosphate
Adenosine Diphosphate
Animals
Animals
Blood Platelets
Blood Platelets
Drug Evaluation, Preclinical
Drug Evaluation, Preclinical
Female
Female
Healthy Volunteers
Healthy Volunteers
Humans
Humans
Inhibitory Concentration 50
Inhibitory Concentration 50
Male
Male
Mice
Mice
Models, Animal
Models, Animal
Molecular Docking Simulation
Molecular Docking Simulation
Platelet Aggregation
Platelet Aggregation
Platelet Aggregation Inhibitors
Platelet Aggregation Inhibitors
Platelet Function Tests
Platelet Function Tests
Platelet Glycoprotein GPIIb-IIIa Complex
Platelet Glycoprotein GPIIb-IIIa Complex
Receptors, Purinergic P2Y12
Receptors, Purinergic P2Y12
Signal Transduction
Signal Transduction
Stilbenes
Stilbenes
Thrombosis
Thrombosis
authors with profiles
Kimberly Ann Watson